You are here
Treatment with lithium or amphotericin B
Cardiomyopathy - Treatment with lithium or amphotericin B Factor
Last reviewed for CCPS 18 July 2007.
Investigative Documents
Medical Report - Treatment with Lithium or Amphotericin B - Cardiomyopathy [MR9385] Preliminary questions [38353]
38355 the veteran was being treated with lithium or amphotericin B for treatment of an illness or injury which is identifiable. 38356 — the veteran has established the causal connection between being treated with lithium or amphotericin B and operational service for cardiomyopathy. 38357 — the veteran has established the causal connection between being treated with lithium or amphotericin B and operational service for the clinical onset of cardiomyopathy. or 38358 — the veteran has established the causal connection between being treated with lithium or amphotericin B and operational service for the clinical worsening of cardiomyopathy. Clinical onset and operational service [38357] 38361 — the identified illness or injury, for which the veteran was being treated with lithium or amphotericin B, is causally related to operational service. Clinical worsening and operational service [38358] 38361 — the identified illness or injury, for which the veteran was being treated with lithium or amphotericin B, is causally related to operational service.